Novartis AG (NVS)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 102.09 |
| Open | 101.52 |
| Bid | 100.00 x 800 |
| Ask | 102.43 x 800 |
| Day's range | 101.03 - 101.77 |
| 52-week range | 74.09 - 105.61 |
| Volume | |
| Avg. volume | 1,339,001 |
| Market cap | 211.191B |
| Beta (5Y monthly) | 0.46 |
| PE ratio (TTM) | 28.09 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 3.50 (3.43%) |
| Ex-dividend date | 09 Mar 2023 |
| 1y target est | N/A |
- Zacks
Novartis (NVS) Dips More Than Broader Markets: What You Should Know
Novartis (NVS) closed the most recent trading day at $101.14, moving -0.93% from the previous trading session.
- Zacks
Travere (TVTX) Slumps 41% on Mixed Results From IgAN Drug Study
Data from a confirmatory study shows that Travere's (TVTX) IgAN therapy did not achieve one of its confirmatory secondary endpoints. This will likely hurt the company's chances for the drug's full approval.
- Zacks
Jazz Pharma (JAZZ) Gets EU Nod for Cancer Drug Enrylaze
The approval is based on data from a phase II/III study, which showed that treatment with Jazz's (JAZZ) Enrylaze achieved sustained asparagine activity in two cancer indications.
© 2023 Yahoo. All rights reserved.
